Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 333 followers
Latest posts
Last updated about 10 hours ago
Human medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Date of authorisation: 29/09/2023, Revision: 1, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Date of...
Human medicines European public assessment report (EPAR): Ninlaro, ixazomib, Date of authorisation: 21/11/2016, Revision: 21, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Ninlaro, ixazomib, Date of authorisation...
Human medicines European public assessment report (EPAR): Nexpovio, selinexor, Date of authorisation: 26/03/2021, Revision: 10, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Nexpovio, selinexor, Date of authorisation...
Human medicines European public assessment report (EPAR): Kyprolis, carfilzomib, Date of authorisation: 19/11/2015, Revision: 22, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Kyprolis, carfilzomib, Date of authorisation...
Human medicines European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta), umeclidinium, Date of authorisation: 20/03/2017, Revision: 15, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta), umeclidinium...
Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 98, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 5, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of...
Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Date of authorisation: 15/04/2025, Revision: 5, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Date of authorisation...
Human medicines European public assessment report (EPAR): Signifor, pasireotide, Date of authorisation: 24/04/2012, Revision: 16, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Signifor, pasireotide, Date of authorisation...
Human medicines European public assessment report (EPAR): Iqirvo, elafibranor, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Iqirvo, elafibranor, Date of authorisation...